BOB CORNELL, Vice President
joining CTG in 1994, Cornell has specialized in building
relationships with Japanese healthcare companies for CTG clients.
Cornell is often the main liaison between CTG clients and their
Japanese partners. As such, he helps to identify and
resolve both cross-cultural and complex business problems. Having
lived in Japan for his entire professional life, Bob is near
fluent in Japanese language and the nuances of Japanese culture.
Cornell established in 2003 and continues to manage CTG's
Import Division. CTG now has a network of more than 40 local
distributors, into which it feeds several product lines of
medical devices and accessories. Current target markets
include neurosurgery, ENT, and homecare/rehabilitation.
to joining CTG, Cornell spent 7 years at Takeda Chemical
Industries, Japan’s largest pharmaceutical manufacturer.
He holds the notable distinction of being the first non-Japanese
ever to be based in Takeda’s Osaka headquarters. After
three years there, in Takedafs international division,
working to strengthen ties between Takeda and its then-fledgling
European subsidiaries, Cornell moved to Takeda's OTC sales
division, where he managed over $5 million in annual sales to
300+ pharmacies in the Tokyo metropolitan area, the first
non-Japanese ever to work directly with distributors and
pharmacies in the Japanese OTC market.
Bob has held the following
positions: Director, ResMed, K.K., Director, Total Renal Care
Japan, K.K. and Representative, Oread, Inc. Japan Representative
from the Washington, D.C. area, Bob received his B.A. in Economics
and East Asian Studies from Columbia University. Bob and his
wife now reside in Bunkyo-ku, Tokyo.